Company / Free Cash Flow per Share
Catalyst Pharmaceuticals Partners, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.70
FY2025
5-year range
$0.58 / $1.98
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#36 of 193
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s free cash flow per share of $1.70 is higher than 81% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.26 in FY2018 to $1.98 in FY2024.
Based on SEC 10-K filings.
1.70 in FY2025 with a 5-year CAGR of +31.4%. Top quartile in the Health Care sector.
Improved from $1.34 to $1.70 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +15.6%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Sector benchmark
+108.6% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 14.0% year-over-year.
- Ranks #36 out of 193 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | -14.0% |
| FY2024 | $1.98 | +47.9% |
| FY2023 | $1.34 | +21.4% |
| FY2022 | $1.10 | +91.3% |
| FY2021 | $0.58 | +32.3% |
| FY2020 | $0.44 | +29.3% |
| FY2019 | $0.34 | +231.6% |
| FY2018 | -$0.26 | -17.7% |
| FY2017 | -$0.22 | +0.1% |
| FY2016 | -$0.22 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026